Marx Olivia, Mankarious Marc, Yochum Gregory
Department of Biochemistry & Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA 17033, United States.
Department of Surgery, Division of Colon & Rectal Surgery, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, PA 17033, United States.
World J Biol Chem. 2023 Mar 27;14(2):13-27. doi: 10.4331/wjbc.v14.i2.13.
Early-onset colorectal cancer (EOCRC) has been rising in global prevalence and incidence over the past several decades. Environmental influences, including generational lifestyle changes and rising obesity, contribute to these increased rates. While the rise in EOCRC is best documented in western countries, it is seen throughout the world, although EOCRC may have distinct genetic mutations in patients of different ethnic backgrounds. Pathological and molecular characterizations show that EOCRC has a distinct presentation compared with later-onset colorectal cancer (LOCRC). Recent studies have identified DNA, RNA, and protein-level alterations unique to EOCRC, revealing much-needed biomarkers and potential novel therapeutic targets. Many molecular EOCRC studies have been performed with Caucasian and Asian EOCRC cohorts, however, studies of other ethnic backgrounds are limited. In addition, certain molecular characterizations that have been conducted for LOCRC have not yet been repeated in EOCRC, including high-throughput analyses of histone modifications, mRNA splicing, and proteomics on large cohorts. We propose that the complex relationship between cancer and aging should be considered when studying the molecular underpinnings of EOCRC. In this review, we summarize current EOCRC literature, focusing on sporadic molecular alterations in tumors, and their clinical implications. We conclude by discussing current challenges and future directions of EOCRC research efforts.
在过去几十年中,早发性结直肠癌(EOCRC)的全球患病率和发病率一直在上升。包括代际生活方式改变和肥胖率上升在内的环境因素导致了这些发病率的增加。虽然EOCRC发病率的上升在西方国家有最充分的记录,但在全世界都能看到这种情况,尽管不同种族背景的患者中EOCRC可能有不同的基因突变。病理和分子特征表明,与晚发性结直肠癌(LOCRC)相比,EOCRC有不同的表现。最近的研究已经确定了EOCRC特有的DNA、RNA和蛋白质水平的改变,揭示了急需的生物标志物和潜在的新型治疗靶点。许多关于EOCRC的分子研究是在白种人和亚洲EOCRC队列中进行的,然而,其他种族背景的研究有限。此外,一些针对LOCRC进行的分子特征研究尚未在EOCRC中重复进行,包括对大型队列的组蛋白修饰、mRNA剪接和蛋白质组学的高通量分析。我们建议,在研究EOCRC的分子基础时,应考虑癌症与衰老之间的复杂关系。在这篇综述中,我们总结了当前关于EOCRC的文献,重点关注肿瘤中的散发性分子改变及其临床意义。我们通过讨论当前EOCRC研究工作面临的挑战和未来方向来结束本文。